Digital Diabetes Management Market Size By Product Type (Devices {Smart Glucose Meters, CGM, Insulin Pumps & Patches, Insulin Pens}, By Device Type [Wearable, Handheld], Services {Diabetes Apps, Software}), By Patient Type (Type 1, Type 2), By End-Use (Hospitals, Home Settings, Diagnostic Centers & Clinics), COVID-19 Impact Analysis, Regional Outlook, Competitive Market Share & Forecast, 2021 – 2027

Industry trends

Digital Diabetes Management Market size exceeded USD 13 billion in 2020 and is poised to grow at 18.8% CAGR between 2021 and 2027. Rising diabetic population pool coupled with increasing awareness about digital diabetes devices will drive the market growth.
 

Get more details on this report - Request Free Sample PDF
 

The rising cost of diabetes and increasing awareness about diabetes preventive care are the major factors contributing to the market expansion. Diabetic people are highly dependent on technology in order to monitor and manage as well as to seek timely treatment. Thus, technological transformation allows diabetes patients to manage their health with digital devices to track, monitor, and share lifestyle data with healthcare professionals. Increasing usage of mobile applications and wearable activity tracker devices are continuously improving patient’s health and helps in the management of diabetes.
 

Moreover, the advent of AI and big data analytics is transforming the field of digital diabetes. The growth in bigdata analytics will provide access to large unstructured and real time structured data to both patients and healthcare professionals. The AI based digital diabetes devices will allow patients to receive customized solution for hypoglycaemia control.
 

Get more details on this report - Request Free Sample PDF
 

Increasing number of product launches and rising awareness about diabetes preventive care

Get more details on this report - Request Free Sample PDF
 

The CGM devices segment is expected to register growth of over 18.7% during the forecast period, due to increasing technological collaborations coupled with increasing number of product launches. For instance, in November 2020, Abbott launched FreeStyle Libre system in India. The device provides real time glucose reading on demand and complete overview of person’s glucose level.
 

Increasing awareness about self-diabetes preventive care

Homecare settings segment is predicted to expand at 19.1% CAGR through 2027, owing to the increasing awareness about diabetes preventive care. Moreover, user friendly interface of these advanced digital diabetes devices will continue to boost the product demand in homecare settings.
 

COVID-19 has positively impacted the digital diabetes management market as the use of mobile applications and connected devices has increased exponentially during the pandemic. The demand for self-monitoring of blood glucose and wearable diabetes have also risen due recently. Several inpatient and outpatient diabetes services have considered increase their capacity. There is strong inclination towards minimizing outpatient attendance and movement towards virtual consultation using digital diabetes devices.
 

Increasing usage of digital devices in type 2 diabetes patients

Get more details on this report - Request Free Sample PDF
 

The type 2 diabetes segment value was more than USD 12 billion in 2020. The dominance of this segment is primarily attributed to the presence of large number of type 2 patients. According to the Centers for Disease Control and Prevention (CDC), type 2 diabetes patients account for more than 90% of the total diagnosed cases in the country.
 

The type 2 diabetes patients carry significant morbidity and is leading cause of adult blindness, kidney failure, and lower limb amputation. The key drivers of the segment are the consumption of unhealthy diet, lack of physical activity, and other lifestyle related disorder. Furthermore, increasing number of obese people, rising geriatric population and greater expectancy at a time of birth are boosting the demand for the segment.
 

Adoption of unhealthy lifestyle in North America will stimulate the market growth

North America digital diabetes management market revenue crossed USD 4 billion in 2020, due to presence of industrial leaders and continuous technological advancements in digital devices. Moreover, increasing healthcare expenditure to diabetes and high per capita income are fueling the market demand.
 

The U.S. will dominate the North America market in the coming years on account of high diabetes prevalence and favourable reimbursement policies. For instance, in September 2020, Abbott announced the availability of its FreeStyle Libre 2 CGM system in U.S. to Medicare patient for better management of diabetes. Moreover, high adoption of advance diabetes devices coupled with continuous technological advancements will further propel the U.S. market size.
 

Major market players are collaborating with start-ups

Some of the key players operating in the market include Medtronic Plc, F.Hoffmann-LA Roche Ltd., Abbott Laboratories, Dexcom, Inc., Insulet Corporation, Companion Medical, Ypsomed, Tandem Diabetes, and Glooko, Inc. These players are continuously evolving their products and are involved in technological collaboration to gain larger customer base via competitive advantage.
 

Recent Industry Developments: 

• In November 2020, Medtronic Launched CGM integrated smart insulin pen. The company announced the launch of Inpen that can be integrated with Gaurdian Connect CGM Data. The acquisition would enable Medtronic to expand its customer base and also increase their options for insulin delivery.
   
• In January 2020, Tandem Diabetes Care Inc, announced the launch of its new version of t: slim X2 in U.S. The system can integrate with Dexcom G6 CGM and is the first device that can deliver automatic correction boluses, thereby broadening firm’s portfolio.
   

The digital diabetes management market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027 for the following segments:

Market, By Product Type         

• By Device
  • By Device
    • Smart blood glucose meter
    • Smart CGM
    • Smart insulin pumps
    • Smart insulin pens
  • By Device Type
    • Handheld
    • Wearable
• Services
  • Apps
  • Service/software

Market, By Patient Type

• Type 1
• Type 2

Market, By End-use

• Hospitals
• Home Settings
• Diagnostic Centers & Clinics
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE